This phenomenon is attributed to a physiological mechanism involving HPA axis dysregulation: individuals with PTSD exhibit hyperactivity of corticotropin-releasing hormone (CRH) coupled with subsequent hypersensitivity of glucocorticoid receptors. This evidence concerns the gene NR3C1 and post-traumatic stress disorder.